The Institutes for Pharmaceutical Discovery, L.L.C. 23 Business Park Drive Branford, CT 06405 (203) 315-4000 info@iba-analytics.com
Receive updates by adding your email address to our list.
Add Your Email
The DMPK group has developed the following models to identify compounds that have suitable pharmacokinetic, metabolic, and safety characteristics to advance to pre-IND status.